If you are thinking of investing in the stock market, then today we are going to talk about Remedium Lifecare share price targets for the years 2025 to 2030 so that you will be able to understand whether you should invest your money in this company or not.
Join Us On WhatsApp GroupRemedium Lifecare Company Overview
Remedium Lifecare Limited is a well-known pharmaceutical company in India that is moving ahead by focusing on its advanced research and development in the field of healthcare and life-saving medicines.
If we talk about its product portfolio, it includes life-saving drugs, healthcare products, and wellness solutions. For information, let us tell you that today the company is expanding its reach in the domestic market as well as the international market, due to which its stock price may see a big jump in the future.
| Company Name | Remedium Lifecare Limited |
| Founded | 1988 |
| Headquarters | Mumbai, Maharashtra |
| Industry | Pharmaceuticals / Healthcare |
| Managing Director | Siddharth Shah |
| Stock Exchange Listing | BSE |
Also Read: South Indian Bank Share Price
Remedium Lifecare Share Price Target 2025 to 2030
| Year | Share Price Target |
|---|---|
| Remedium Lifecare Share Price Target 2025 | ₹6.25 |
| Remedium Lifecare Share Price Target 2026 | ₹9.80 |
| Remedium Lifecare Share Price Target 2027 | ₹12.44 |
| Remedium Lifecare Share Price Target 2028 | ₹14.57 |
| Remedium Lifecare Share Price Target 2029 | ₹17.98 |
| Remedium Lifecare Share Price Target 2030 | ₹20.00 |
Remedium Lifecare Target Price 2025
If we talk about Remedium Lifecare’s share price target for 2025, then it can be 6.25 INR. Actually, this target will depend on the market conditions as well as how the company is continuously growing. Investors should keep in mind that the stock market is volatile, so it is very important to make a better strategy for long-term investment.
Remedium Lifecare Target Price 2026
Talking about Remedium Lifecare’s share price target for 2026, it is expected to be 9.80 INR. During this time, the company’s financial performance and changing trends in the industry will be monitored, which will provide important insights for investors. If the company wants to achieve this target, then it will have to strengthen its growth strategies.
Remedium Lifecare Target Price 2030
Now let’s talk about Remedium Lifecare’s share price target for 2030, which can reach up to 20.00 INR. At this time, if the company successfully executes its business model and changes its product portfolio according to the market demand, then it is absolutely possible to achieve this target. The growth that will happen this year will provide a long-term investment opportunity for investors.
Also Read: Visesh Infotech Share Price
Remedium Lifecare Ltd Shareholding Pattern
- Retail & Other: 98.89%
- Promoters: 1.11%
- Foreign Institution: 0.00%
- Mutual Funds: 0.00%
- Other Domestic Institution: 0.00%
Remedium Lifecare Ltd Fundamental Analysis
| Metric | Value |
|---|---|
| Market Cap | ₹160.22 Cr. |
| ROE | 122.76% |
| ROCE | 99.51 % |
| P/E | 0 |
| P/B | 1.67 |
| Div. Yield | 0% |
| Book Value | ₹1.07 |
| Face Value | ₹1 |
| EPS (TTM) | ₹-0.55 |
| 52 Week High | ₹19.14 |
| 52 Week Low | ₹1.21 |
Also Read: GRSE Share Price
Remedium Lifecare Ltd Income Statement
| (INR) | 2024 | Y/Y Change |
|---|---|---|
| Revenue | 40.42B | +692.75% |
| Operating expense | 69.27M | -26.34% |
| Net income | 327.30M | +503.20% |
| Net profit margin | 0.81 | -23.58% |
| Earnings per share | — | — |
| EBITDA | 334.54M | +398.11% |
| Effective tax rate | 35.13% | — |
Remedium Lifecare Ltd Balance Sheet
| (INR) | 2024 | Y/Y Change |
|---|---|---|
| Cash & short-term investment | 15.24M | -93.03% |
| Total assets | 19.48B | +68.76% |
| Total liabilities | 19.05B | +66.54% |
| Total equity | 429.58M | — |
| Shares outstanding | 403.20M | — |
| Price to Book | 5.82 | — |
| Return on assets | 1.35% | — |
| Return on capital | 37.60% | — |
Remedium Lifecare Ltd Cash Flow
| (INR) | 2024 | Y/Y Change |
|---|---|---|
| Net income | 327.30M | +503.20% |
| Cash from operations | -741.61M | -461.76% |
| Cash from investing | 938.00K | +319.67% |
| Cash from financing | 538.29M | +144,414.75% |
| Net change in cash | -203.32M | -199.57% |
| Free cash flow | -922.25M | -583.87% |
Remedium Lifecare Ltd Peer Companies
- Nykaa
- Brainbees Solutions
- Cello World
- Aegis Logistics
- V-Mart Retail
- Honasa Consumer
- Redtape
- MMTC
- Medplus Health Services
- Arvind Fashion
Also Read: Monotype India Share Price
Conclusion
Remedium Lifecare Limited has strengthened its R&D capabilities over time, and due to this, the company keeps launching new innovative products every year. Remedium Lifecare’s share price target for 2025, 2026, 2027, 2028, 2029, and 2030 and its strong financials make it a favorite company among investors. Investing in Remedium Lifecare Limited can prove to be beneficial for long-term investors.
FAQs
Is Remedium Lifecare a good company to buy?
Yes, looking at its current financial position, we can say that it is absolutely right to buy shares of this company.
What is the old name of Remedium Lifecare?
The old name of Remedium Lifecare Limited is Roxy Exports Limited.
What does Remedium Lifecare do?
Remedium Lifecare Limited is a pharmaceutical company that operates in the healthcare industry.
Disclaimer: The information in this article is for educational purposes only, and the targets mentioned in it are given as suggestions by market analysts. Therefore, before investing your money in any company, it is mandatory to get complete information about the company and consult your financial advisor.
Disclaimer: The stock market updates shared by DateUpdateGo are solely for general information and learning purpose only. They are not meant to serve as an investment advice. Individuals should always seek guidance from a certified financial advisor before making any investment-related choices.